Precision bioanalytical

For high-throughput analysis, it is important to increase the specihcity of each bioanalytical method. The enhancement of chromatographic resolution presents various limitations. Better selectivity can be obtained with TOF mass analyzers that routinely provide more than 5000 resolution (full width at half-mass or FWHM). The enhanced selectivity of a TOF MS is very attractive for problems such as matrix suppression and metabolite interference. In one report of quantitative analysis using SRM, TOF appeared less sensitive than triple quadrupole methods but exhibited comparable dynamic range with acceptable precision and accuracy.102... 

The first field of application for SdFFF were latex beads, which were used either to test the channels or to produce separation results alternative to other separation techniques. PS nanoparticles used as model surfaces for bioanalytical work have been analyzed by SdFFF [39]. The appealing feature of SdFFF is its ability to characterize particle adlayers—by direct determination of the mass increase performed by observing the differences in retention between the bare and coated particles—with high precision and few error sources the mass of the coating is determined advantageously on a per particle basis. 

The fundamental parameters for bioanalytical validations include accuracy, precision, selectivity, sensitivity, reproducibility, stability of the drug in the matrix under study storage conditions, range, recovery, and response function (see Section 8.2.1). These parameters are also applicable to microbiological and ligand-binding assays. However, these assays possess some unique characteristics that should be considered during method validation, such as selectivity and quantification issues. 

Partial Validation. Partial validations are modifications of already validated bioanalytical methods. Partial validation can range from as little as one intraassay accuracy and precision determination to a nearly full validation. Typical bioanalytical method changes that fall into this category include but are not limited to ... 

The magnitude of the uncertainty associated with a measurement should always be evaluated even if method development is able to generate the best, error-free standard curve possible in order to obtain the best, error-free concentration values for the unknown. Precision and accuracy values define the compromise between the demand for certainty in reported results and the inherent uncertainty in bioanalytical measurement. Precision and Accuracy are the most important parameters used to set the performance standards of bioanalytical methods. They define if the zone of uncertainty connected with the data produced by the method is or is not acceptable for the specific task [13,21]. 

Internal Standard. The use of internal standard is critical in bioanalytical methods to improve precision and accuracy. The role of internal standard is to mimic the analyte of interest. It should be added before sample preparation/extraction to account for losses and errors introduced during the process. The more sample handling steps there are, the greater the error becomes, because errors are additive. In this case, the use of internal standard minimizes errors significantly. 

The amount of internal standard added should be similar to the amount of analyte contained in the sample. In fact, errors are minimized when the relative responses for analyte and internal standard are comparable. If a wide concentration range is to be measured, the amount of internal standard should be selected to maximize precision where it is critically important. As a general rule, with a six-level calibration curve, the internal standard concentration, should be between the second and third calibration standard concentration depending on the relative instrument response for analyte and internal standard and precision at the LLOQ level (i.e., internal standard should be closer to LLOQ if the precision of the LLOQ is low). Many bioanalytical laboratories use a written policy for rejecting sample with low internal standard even though it is not suggested by the 2000 Washington conference final report. 

Even if a reconstitution solvent blank is normally used to evaluate carryover during validation and sample analysis, it is suggested to use all three types of blank as mentioned earlier for carryover evaluation during the method development. As considered previously (see Section 8.3.2) in the quantitative evaluation of carryover, linearity of detection together with sufficient accuracy and precision below LLOQ should be assumed. This assumption is questionable, and for this reason some bioanalytical laboratories have chosen different criteria to evaluate the carryover. 

Quality Control (QC) QC samples are used to check the performance of the bioanalytical method as well as to assess the precision and accuracy of the results of postdose samples. QC samples are prepared by spiking the analyte of interest and the IS into a blank/control matrix and processing similar to the postdose samples. QC samples cover the low (3 x LLOQ LLOQ = lower limit of quantitation), medium, and high (70-85% of ULOQ ULOQ = upper limit of quantitation) concentration ranges of the standard curve and are spaced across the standard curve and the postdose sample batch. 

Selected chemical employed to measure the sensitivity of the test organisms in order to establish confidence in toxicity data obtained for a given test sample (or a batch of test samples). In most instances, a toxicity test with a reference toxicant is performed i) to confirm that test organisms (or cells) are in good physiological health for bioanalytical purposes at the time the test sample is evaluated, and ii) to assess the precision and reliability of results obtained by the laboratory for that reference toxicant. The toxicant selected should meet different properties as defined by Environment Canada, 1990. Volume 1(2,3,6,7,14), Volume 2(11). 

Compared to other bioanalytical methods such as high-performance liquid chromatography (HPLC), the methods used to quantitate mAbs often display less precision and a higher between-day variability. In choosing a bioanalytical method it must also be considered that some assays measure the unbound fraction, the bound fraction, or both. When using FACS, only the fraction of the therapeutic antibody that is bound to its antigen on the cells is counted. In contrast, ELISA measures only the unbound fraction in serum that can react with the offered antigen. 

Bio analytical Methodology Bioanalytical methods for BA and BE studies should be accurate, precise, selective, sensitive, and reproducible. A separate FDA guidance entitled Bioanalytical Method Validation (May 2001) is available to assist sponsors in validating bioanalytical methods. 

Characterize bioanalytical method, including sample preparation procedure, for linearity, sensitivity, specificity, precision, and accuracy. 

After a decade of intensive development, ACE is widely recognized nowadays as a powerful tool in the study of different kinds of biomolecular interactions. More than 400 scientific reports related to ACE can be found in the literature, covering almost all fields of bioanalytical chemistry. Unique features of homogeneous analysis coupled with the separation power of CE makes ACE especially favorable for precise determination of affinity parameters, such as binding constants and binding stoichiometries. Automation, multicapillary arrows, and chip technology increase throughput of ACE analysis, a factor which still limits... 

Micropipettes, also referred to as autopipettors (or pipettors), are key tools for the bioanalytical chemist. These are used to very accurately and precisely measure small volumes ranging from 1 to 1000 pi. While there are various manufacturers, most micropipettes have the same standard features and are either single channel or multicharmel, and may be semi- or fully automatic (see Figure 2.4). 

One of the critical steps in qualitative and quantitative analysis is the sample preparation procedure. Sample preparation step can affect specificity, sensitivity, accuracy, precision, and throughput of a bioanalytical procedure. In addition to development and optimization of the chemistry involved in sample processing, the use of semiautomated or fully automated protocols has been... 

As for any bioanalytical method, the extent of validation for an immunoassay should be related to the intended application of the assay. Thus, if an immunoassay is intended to support rapid screening in discovery R D, the characterization of specificity and the accuracy and precision specifications may be less stringent than if the assay is used to support pre-clinical and clinical development studies. Indeed, an assay for discovery support may be designed to detect active metabolites as well as parent molecule, so that... 

---